Study of CS-3150 in Hypertensive Patients With Type 2 Diabetes and Albuminuria
Status:
Completed
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
To examine antihypertensive effect and safety of administration of CS-3150 in combination
with ARB or ACE inhibitor in hypertensive patients with type 2 diabetes and albuminuria.